Katie J. Doores

Best Publications

• Broad neutralization coverage of HIV by multiple highly potent antibodies

  Laura M. Walker;Michael Huber;Michael Huber;Katie J. Doores;Katie J. Doores;Emilia Falkowska;Emilia Falkowska

  1773
  Citations

• Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.

  Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  1214
  Citations

• A dynamic COVID-19 immune signature includes associations with poor prognosis.

  Adam G. Laing;Anna Lorenc;Irene del Molino del Barrio;Irene del Molino del Barrio;Abhishek Das;Abhishek Das

  962
  Citations

• A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

  Robert Pejchal;Katie J. Doores;Katie J. Doores;Laura M. Walker;Reza Khayat

  872
  Citations

• Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

  Leticia Monin;Adam G Laing;Miguel Muñoz-Ruiz;Duncan R McKenzie

  534
  Citations

• Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers

  Emilia Falkowska;Khoa M. Le;Khoa M. Le;Alejandra Ramos;Alejandra Ramos;Katie J. Doores;Katie J. Doores;Katie J. Doores

  463
  Citations

• Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens

  Katherine Doores;Camille Bonomelli;David J Harvey;Snezana Vasiljevic

  433
  Citations

• Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.

  Michael J. Carter;Michael J. Carter;Matthew Fish;Matthew Fish;Aislinn Jennings;Aislinn Jennings;Katie J. Doores

  429
  Citations

• Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

  Leopold Kong;Jeong Hyun Lee;Katie J Doores;Katie J Doores;Katie J Doores;Charles D Murin

  421
  Citations

• Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.

  Jean-Philippe Julien;Devin Sok;Reza Khayat;Jeong Hyun Lee

  411
  Citations

• Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16

  Katherine Doores;Katherine Doores;Dennis R Burton;Dennis R Burton

  361
  Citations

• Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein

  Anna Janina Behrens;Snezana Vasiljevic;Laura K. Pritchard;David J. Harvey

  284
  Citations

• Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

  Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  281
  Citations

• The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade

  Camille Bonomelli;Katherine Doores;Katherine Doores;D Cameron Dunlop;Victoria Thaney

  250
  Citations

• The effect of spike mutations on SARS-CoV-2 neutralization.

  Chloe Rees-Spear;Luke Muir;Sarah A. Griffith;Judith Heaney

  221
  Citations

• Exploring and exploiting the therapeutic potential of glycoconjugates

  Katie J. Doores;David. P. Gamblin;Benjamin G. Davis

  211
  Citations

• Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV

  Devin Sok;Devin Sok;Katie J. Doores;Bryan Briney;Bryan Briney;Khoa M. Le;Khoa M. Le

  205
  Citations

• Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.

  Toshana L. Foster;Harry Wilson;Shilpa S. Iyer;Karen Coss

  193
  Citations

• Structural constraints determine the glycosylation of HIV-1 envelope trimers

  Laura K. Pritchard;Snezana Vasiljevic;Gabriel Ozorowski;Gemma E. Seabright

  185
  Citations

• The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.

  Helena Winstone;Maria Jose Lista;Alisha C. Reid;Clement Bouton

  177
  Citations